A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells

Monoclonal antibodies directed to the B-cell-specific CD20-antigen are successfully used for the treatment of lymphomas and autoimmune diseases. Here, we compare the anti-B-cell activity of three different antibodies directed to CD20: (i) a chimeric, monospecific antibody, (ii) an Fc-optimized varia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Ther
Hlavní autoři: Nalivaiko, Kristina, Hofmann, Martin, Kober, Karina, Teichweyde, Nadine, Krammer, Peter H, Rammensee, Hans-Georg, Grosse-Hovest, Ludger, Jung, Gundram
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817817/
https://ncbi.nlm.nih.gov/pubmed/26581163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.209
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky